Curative Biotechnology, Inc.
CUBT
$0.0115
-$0.0003-2.54%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -1.42M | -1.29M | -1.40M | -935.90K | -1.02M |
| Total Depreciation and Amortization | 2.00K | 2.00K | 2.00K | -4.30K | 2.00K |
| Total Amortization of Deferred Charges | 263.60K | 250.00K | 83.30K | -46.30K | -1.20K |
| Total Other Non-Cash Items | 265.70K | 77.40K | 231.90K | -19.60K | 500.40K |
| Change in Net Operating Assets | 712.20K | 647.40K | -106.70K | 426.40K | 99.20K |
| Cash from Operations | -175.00K | -310.70K | -1.19M | -579.80K | -415.30K |
| Capital Expenditure | -- | -- | -- | -6.80K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.30K | -4.40K | -36.30K | 0.00 | -6.00K |
| Cash from Investing | -36.30K | -4.40K | -36.30K | -6.80K | -6.00K |
| Total Debt Issued | 25.20K | 200.00K | 956.70K | 70.00K | 0.00 |
| Total Debt Repaid | -34.70K | -26.00K | -26.00K | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 548.00K | 425.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.60K | -42.30K | -68.70K | -93.00K | -- |
| Cash from Financing | 85.10K | 131.70K | 861.90K | 525.00K | 425.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.20K | -183.40K | -360.00K | -61.60K | 3.70K |
